QS Investors, LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 246 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
QS Investors, LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$272,000
-51.7%
13,036
-45.0%
0.00%
-50.0%
Q2 2020$563,000
+31.9%
23,6940.0%0.01%
+14.3%
Q1 2020$427,000
-31.8%
23,694
-10.2%
0.01%
+16.7%
Q4 2019$626,000
-13.8%
26,3940.0%0.01%
-25.0%
Q3 2019$726,000
-16.9%
26,3940.0%0.01%
-11.1%
Q2 2019$874,000
-5.5%
26,3940.0%0.01%
-10.0%
Q1 2019$925,000
+5.5%
26,3940.0%0.01%
-9.1%
Q4 2018$877,000
-34.0%
26,3940.0%0.01%
-15.4%
Q3 2018$1,329,000
-15.9%
26,3940.0%0.01%
-18.8%
Q2 2018$1,580,000
+48.1%
26,394
+13.3%
0.02%
+45.5%
Q1 2018$1,067,000
+15.0%
23,287
+0.0%
0.01%
+22.2%
Q4 2017$928,0000.0%23,277
+0.3%
0.01%
+12.5%
Q3 2017$928,000
-7.2%
23,2040.0%0.01%
-11.1%
Q2 2017$1,000,000
+240.1%
23,204
+20.2%
0.01%
+200.0%
Q1 2016$294,000
+20.0%
19,300
+6.0%
0.00%
+50.0%
Q4 2015$245,00018,2000.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 699,432$35,216,0004.25%
Provident Investment Management, Inc. 590,269$29,720,0004.23%
CAPITAL MANAGEMENT CORP /VA 225,232$11,340,0002.90%
FALCON POINT CAPITAL, LLC 188,341$9,483,0002.04%
Ranger Investment Management 600,464$30,233,0002.00%
NEUMEIER POMA INVESTMENT COUNSEL LLC 471,260$23,728,0001.96%
KOPP INVESTMENT ADVISORS LLC 41,700$2,100,0001.77%
SHAKER INVESTMENTS LLC/OH 49,617$2,498,0001.54%
Bruce & Co., Inc. 148,058$7,454,0001.44%
Bridge City Capital, LLC 45,843$2,308,0001.43%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders